Related Experiment Video
Updated: Aug 4, 2026

Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis
Published on: March 9, 2018
The ergosterol biosynthesis pathway, transporter genes, and azole resistance in Aspergillus fumigatus
M E da Silva Ferreira1, A L Colombo, I Paulsen
1Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Ciências e Letras de Ribeirão Preto, Universidade de São Paulo, São Paulo, Brazil.
Abstract:
The continuous use of triazoles can result in the development of drug resistance. Azole-resistant clinical isolates, spontaneous and induced mutants of Aspergillus fumigatus have been documented. The azoles block the ergosterol biosynthesis pathway by inhibiting the enzyme 14-alpha-demethylase, product of the CYP51. Fungal azole resistance involves both amino acid changes in the target site that alter drug-target interactions and those that decrease net azole accumulation. The reduced intracellular accumulation has also been correlated with overexpression of multidrug resistance (MDR) efflux transporter genes of the ATP-binding cassette (ABC) and the major facilitator superfamily (MFS) classes. About 20 genes are involved in the A. fumigatus ergosterol biosynthesis pathway. There are several duplicated genes in this pathway. Interestingly, erg3 and erg11 showed two copies in A. fumigatus. In general, Aspergillus spp. have proportionally more MFS transporter encoding genes than Saccharomyces cerevisiae, S. pombe, and Neurospora crassa. The drug H+ (12 and 14 spanners) sub-families are also proportionally greater than in the other species. Although the numbers of ABC transporter encoding genes are comparable, again the Aspergillus spp. have more ABC transporters related to multidrug permease than the other fungal species.
Insights
Continuous triazole use drives antifungal resistance in Aspergillus fumigatus. Resistance mechanisms include target mutations and reduced drug accumulation due to efflux pumps.
Area of Science:
- Mycology
- Molecular Biology
- Drug Resistance
Background:
- Continuous triazole use leads to antifungal resistance.
- Azole resistance in Aspergillus fumigatus is a growing clinical concern.
- Azoles target the ergosterol biosynthesis pathway by inhibiting CYP51 (14-alpha-demethylase).
Purpose of the Study:
- To investigate the mechanisms of azole resistance in Aspergillus fumigatus.
- To understand the role of efflux transporters in reduced drug accumulation.
- To compare gene duplication and transporter gene families in Aspergillus spp. versus other fungi.
Main Methods:
- Analysis of azole-resistant clinical isolates and mutants of Aspergillus fumigatus.
- Examination of the ergosterol biosynthesis pathway and associated gene duplications.
- Comparative genomics of transporter genes (ABC and MFS) in Aspergillus spp. and other fungal species.
Main Results:
- Azole resistance involves target site alterations and decreased intracellular accumulation.
- Reduced accumulation is linked to overexpression of multidrug resistance (MDR) efflux transporters (ABC and MFS).
- Aspergillus fumigatus has duplicated erg3 and erg11 genes; Aspergillus spp. possess proportionally more MFS and specific ABC transporter genes than other fungi.
Conclusions:
- Fungal azole resistance is multifactorial, involving target modification and active efflux.
- Overexpression of MDR transporters significantly contributes to azole resistance.
- Aspergillus spp. exhibit unique genetic features, including gene duplications and expanded transporter families, potentially influencing drug resistance profiles.
Related Concept Videos
Overview of Fungi
Fungal Group Zygomycota
Fungal Phylum Microsporidia
Fungal Phylum Ascomycota
Candidiasis
Antifungal Agents

